<% (signals.list.current.rate).substr(0,7) %>
<% signal.analyst %>
Last Updated: May 04, 2026 03:33:23 PM (GMT)
3SBI: The current market price is 22.25, with no percentage change reported from the previous price.
Support and Resistance Levels The current support levels are 22.25, 22.25, and 22.25. The resistance levels are 22.25, 22.25, and 22.25. The pivot point is 22.25.
Indicators The RSI is at 100, indicating overbought conditions with a sustained history of 100. The ATR and standard deviation are both at 0. The Parabolic SAR is at 22.25, maintaining a consistent trend level. The SMA and EMA (5, 10, and 20) are all at 22.25, indicating a flat market situation.
Market Sentiment Since the current price is at the pivot point of 22.25, the market outlook appears neutral, supported by RSI and static trend indicators.
About (3SBI) 3SBio Inc.
Company Background
3SBio Inc., symbol 3SBI (TRADU:3SBI), is a leading biotechnology company based in Shenyang, China, specializing in the research, development, manufacturing, and commercialization of biopharmaceutical products. Founded in 1993, 3SBio focuses on innovative therapies in oncology, nephrology, dermatology, and autoimmune diseases. The company has built a robust product portfolio that includes recombinant proteins, monoclonal antibodies, and other biologic drugs addressing significant unmet medical needs. With vertically integrated operations covering R&D, production, and distribution, 3SBio is dedicated to advancing high-quality, affordable biologics to improve patient outcomes both in China and globally.
Market Position
3SBio holds a strong position in China’s biopharmaceutical industry as one of the country’s earliest and most successful biologics developers. The company is recognized for its leadership in recombinant protein drugs, particularly erythropoietin (EPO) and other hematology-related therapies. Through its extensive research platform and strategic collaborations with global pharmaceutical firms, 3SBio continues to expand its therapeutic pipeline in oncology, dermatology, and autoimmune treatments. Its advanced biomanufacturing capabilities—compliant with global Good Manufacturing Practice (GMP) standards—enable large-scale production and international distribution. The company’s growing presence in overseas markets, supported by a strong intellectual property portfolio and expanding clinical programs, positions it among China’s most globally competitive biopharma enterprises.
Key Financial and Industry Highlights
3SBio demonstrates steady financial performance driven by strong sales of its core biologics, consistent R&D investment, and expanding product commercialization. The company’s diversified revenue base includes both proprietary and licensed biologic products, providing resilience against market fluctuations. Ongoing advancements in biosimilars, antibody-drug conjugates (ADCs), and targeted cancer therapies underscore 3SBio’s commitment to innovation. The firm also continues to invest in digital transformation and global partnerships to enhance its R&D efficiency and accelerate clinical development.
As China’s biopharmaceutical sector continues to grow rapidly, 3SBio is well-positioned to capitalize on rising healthcare demand and government support for domestic innovation. Its focus on sustainable growth, scientific excellence, and patient-centered innovation ensures a strong foundation for long-term success. With a proven track record in biologics development and commercialization, 3SBio Inc. remains a key player in shaping the future of biotechnology and precision medicine in China and worldwide.
How to Buy or Trade 3SBio Inc Stock (3SBI) with AvaTrade
Trading or investing in 3SBio Inc stock through AvaTrade starts with opening a verified trading account. After registration, complete the KYC verification process by submitting your ID and proof of address, then fund your account using a supported payment method such as bank transfer, debit card, or e-wallet. Once your funds reflect, log into the AvaTrade platform or mobile app and search for the ticker symbol 3SBI, which represents 3SBio Inc. Before placing a trade, review the live 3SBio Inc share price, market trend, spread, leverage options, and recent market news that could impact the stock price.
The next step is deciding whether you want to buy or sell 3SBio Inc stock. Traders expecting the price to rise typically open a Buy position, while traders expecting weakness in the sector may open a Sell position using CFDs. Enter your preferred trade size, then apply risk management tools such as a stop-loss to limit downside exposure and a take-profit order to secure profits automatically. After confirming the trade, monitor key drivers including 3SBio Inc earnings reports, product or service announcements, business segment performance, revenue growth, and overall stock market sentiment. Many traders also use technical indicators such as moving averages, RSI, and support/resistance levels available on the AvaTrade platform to improve timing and trading decisions.
Related Stocks
Sidebar rates
- <% signal.pair %>
<% signals.active.Current.rate.substr(0,7) %>
